Power Shifts In Pharmacy Benefit Manager Landscape Impact Pharmaceutical
Changing Dynamics in Lives Coverage, Clinical Programs and Specialty Drug
Management Mean Tighter Control for Pharmacy Benefit Managers (PBMs),
According to HealthLeaders-InterStudy
NASHVILLE, Tenn., April 24, 2013
NASHVILLE, Tenn., April 24, 2013 /PRNewswire/ --HealthLeaders-InterStudy, the
leading provider of managed care market intelligence, analyzes several streams
of proprietary data on Pharmacy Benefit Managers (PBMs) to pull out key trends
and the accompanying implications for pharmaceutical companies. PBMs are
stepping up their game in 2013—developing leaner, discounted pharmacy
networks, adding sophistication to clinical programs and applying a host of
management strategies on specialty drugs.
Ongoing consolidation in the industry has concentrated power in two big
PBMs—Express Scripts and CVS Caremark—which now control pharmacy benefits for
more than 60 percent of the insured members enrolled in U.S. managed care
plans. Express Scripts alone commands nearly half the U.S. commercial market
share, but will give up a substantial portion of that market share to
UnitedHealth Group's PBM by the end of 2013.
"As midmarket competition heats up, PBMs like Catamaran and Prime Therapeutics
become more important to pharmaceutical companies planning a market access
strategy," explains Chris Lewis, Senior Market Analyst at
HealthLeaders-InterStudy, "and a clear grasp of the implications of what's
happening in the industry across the board becomes vital."
HealthLeaders-InterStudy's newly released PBM Landscape Report highlights key
strategies of PBMs, assesses important players and the distinctive
competencies they bring—and anticipates the implications this competitive and
consolidating marketplace will have on Pharma. The PBM Landscape Report is
part of the PBM Profiles section of the Pharmacy Benefit Evaluator.
Upcoming Open Webinar!
PBMs in 2013: Concentrated Power, Midmarket Competition and Tighter Control
May 23, 2013 | 2pm Eastern | 11am Pacific
Senior Market Analyst Chris Lewis of HealthLeaders-InterStudy, author of the
PBM Profiles section of the Pharmacy Benefit Evaluator, shares relevant,
actionable insight from the PBM Landscape Report in an upcoming webinar. For
more information and to register, please click here.
About Pharmacy Benefit Evaluator
With comprehensive analysis of national and local health plans' pharmacy
benefit structure and spending, Pharmacy Benefit Evaluator provides the
insights needed to identify plans and pharmacy benefit managers (PBMs) that
offer the greatest return for partnering. PBM Profiles provide data on covered
lives and plan-PBM affiliation. An interactive interface illustrates
state-by-state coverage including key health plan relationships and where the
PBM manages the formulary.
HealthLeaders-InterStudy, a Decision Resources Group company, is the
authoritative source for managed care data, analysis, and news.
HealthLeaders-InterStudy is part of the Market Access Business Unit at
Decision Resources Group which also includes Abacus International, Fingertip
Formulary, Pinsonault, and PharmaStrat. Find out more at www.hl-isy.com.
About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers
best-in-class, high-value information and insights on important sectors of the
healthcare industry. Clients rely on this analysis and data to make informed
decisions. Please visit Decision Resources Group at
All company, brand or product names contained in this document may be
trademarks or registered trademarks of their respective holders.
For more information, contact:
Lydia Smith Elizabeth Marshall
HealthLeaders-InterStudy Decision Resources Group
Press spacebar to pause and continue. Press esc to stop.